ROBERT NAGELY: Open Payments
NPI 1508430521 · SABETHA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$84 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $92 · 2025 $84
Food & beverage: $84
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 1 | $29 |
| Novo Nordisk Inc | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: Leqembi, Ozempic, LEQVIO, AIRSUPRA.
Industry payments across KS — which companies pay providers there.
